1. Gaviria M , Kilic B . A network analysis of COVID-19 mRNA vaccine patents, 2021. Nature. Available: https://www.nature.com/articles/s41587-021-00912-9
2. Garrison C . What is the ‘know-How Gap’ Problem and how Might it Impact scaling Up Production of Covid-19 related Diagnostics, Therapies And Vaccines? 2020. Medicine Law & Pol. Available: https://medicineslawandpolicy.org/2020/12/what-is-the-know-how-gap-problem-and-how-might-it-impact-scaling-up-production-of-covid-19-related-diagnostics-therapies-and-vaccines/
3. Halabi S . Solving the COVID-19 vaccine product liability problem. CSAS working paper 21-11, 2020. Available: https://administrativestate.gmu.edu/wp-content/uploads/sites/29/2021/02/Halabi-Solving-the-Covid-19-Vaccine-Product-Liability-Problem.pdf
4. O'Sullivan C , Rutten P , Schatz C . Why tech transfer may be critical to beating COVID-19, 2020. McKinsey & Co. Available: https://www.mckinsey.com/industries/life-sciences/our-insights/why-tech-transfer-may-be-critical-to-beating-covid-19
5. Hopkins J . Pfizer’s Global Covid-19 Vaccine Rollout Depends on Two Expert Staffers, 2021. Wall Street Journal. Available: https://www.wsj.com/articles/pfizers-global-covid-19-vaccine-rollout-depends-on-two-expert-staffers-11629464010